Collecting tissue and medical data from patients with inflammatory or invasive breast cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the collection of biospecimens and medical data to create a research tissue registry for patients diagnosed with inflammatory or invasive breast cancer. It aims to gather various samples, including blood, tissue, and stool, along with clinical and imaging data from both newly diagnosed patients and those seeking further treatment. The collected data will be analyzed to improve understanding and treatment of inflammatory breast cancer. Patients will participate in interviews and complete questionnaires to provide comprehensive information.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with clinical diagnosis of primary inflammatory breast cancer (IBC), second primary IBC, or highly suspicious for IBC (MD Anderson patients only).
* Histological diagnosis of invasive breast cancer, or highly suspicious for IBC (MD Anderson patients only) but pending breast cancer diagnosis.
* Be either newly diagnosed, or highly suspicious for IBC (MD Anderson patients only) \[Cohort I\] or have paraffin blocks or up to 20 unstained slides of each representative block(s) from the time of initial diagnosis of IBC(i.e. core biopsy and punch biopsy) and/or from mastectomy (Cohort II-MD Anderson patients only)
* Age \> 18 years
* Able to provide informed consent

Exclusion Criteria:

Where it's running

• Banner - MD Anderson Cancer Center
  Gilbert, Arizona, United States Recruiting
• Banner - MD Anderson Cancer Center - Northern Colorado
  Greeley, Colorado, United States Recruiting
• Baptist - MD Anderson Cancer Center
  Jacksonville, Florida, United States Recruiting
• M D Anderson Cancer Center
  Houston, Texas, United States Recruiting
• MD Anderson in Katy
  Houston, Texas, United States Recruiting
• MD Anderson League City
  Nassau Bay, Texas, United States Recruiting

Study contacts

• Principal investigator: VIcente Valero, MD — M.D. Anderson Cancer Center
• Study coordinator: Jie Willey
• Email: jwilley@mdanderson.org
• Phone: 713-792-3965

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Circulating microRNA changes to predict neoadjuvant chemotherapy response in breast cancer.

  This will test whether changes in blood microRNA levels before and after chemotherapy can help predict who will have a strong tumor response to neoadjuvant chemotherapy for breast cancer.

  Recruiting Atlas University · Istanbul · NCT07289282

• Imlunestrant and Abemaciclib for ER+ Breast Cancer with Minimal Residual Disease

  This Phase 2 trial tests whether taking imlunestrant and abemaciclib together can help people with ER-positive breast cancer who still have detectable cancer after initial treatment.

  Recruiting Phase 2 Jonsson Comprehensive Cancer Center · Los Angeles, California · NCT07191717

• Safety of combining pidnarulex (CX-5461) with trastuzumab deruxtecan for HER2-positive, HER2-low/ultralow breast and other HER2-expressing solid tumors

  This trial tests whether adding pidnarulex to trastuzumab deruxtecan is safe and finds the best dose for adults with HER2-positive, HER2-low/ultralow, or other HER2-expressing advanced or metastatic breast and solid tumors.

  Recruiting at 2 sites Phase 1 National Cancer Institute (NCI) · Boston, Massachusetts and 1 other locations · NCT07137416

• Sentinel lymph node biopsy after neoadjuvant chemotherapy for inflammatory breast cancer

  This trial will test whether sentinel lymph node biopsy after preoperative chemotherapy is feasible and safe for people with inflammatory breast cancer who initially had extensive lymph node involvement.

  Recruiting European Institute of Oncology · Milan · NCT07080944

• Using metformin to treat insulin resistance in women with early-stage breast cancer after chemotherapy

  This study is testing if metformin can help women with early-stage breast cancer who have finished chemotherapy and are struggling with insulin resistance to improve their health.

  Recruiting Phase 3 City of Hope Medical Center · Duarte, California and 2 other locations · NCT06763328

• Single-port robotic breast-conserving surgery through the armpit

  This project will try single-port robotic breast-conserving surgery through the armpit in adults (18–65) with early invasive breast cancer who are candidates for breast conservation and compare it with traditional open breast-conserving surgery.

  Recruiting Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Chongqing, Chongqing Municipality and 1 other locations · NCT06738654

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.